The results of the 14th SWISS BRIDGE Award for Cancer Research were announced on the 30th October, 2014, in an awards ceremony in Zurich.
The award of 500,000 Swiss francs (£326,000) is awarded for outstanding projects in the field of oncology. This year, the prestigious board chose to highlight the important field of cancer immunotherapy.
The award is shared between Professor Laurence Zitvogel, from the Gustave Roussy Comprehensive Cancer Centre, France, and Professor Adrian Ochsenbein, from the Inselspital, Bern University Hospital, Switzerland.
Professor Zitvogel works on the interactions of the intestinal flora with immunotherapeutic treatments. Her current research investigates how intestinal flora can reinforce - and undermine - the effects immunotherapy.
Professor Ochsenbein studies cancer stem cells, which maintain the growth of tumours. He studies the unique environmental conditions that give rise to cancer stem cells, including the immune environment.
The SWISS BRIDGE award was presented by the Chairman of the Scientific Jury, Professor Gordon McVie of the European Institute of Oncology and ecancer.
Professor McVie said that the winners were chosen by a review of over a hundred word-class European oncology projects.
Source: SWISS BRIDGE
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.